389 related articles for article (PubMed ID: 17342048)
1. Production and biological activity of laidlomycin, anti-MRSA/VRE antibiotic from Streptomyces sp. CS684.
Yoo JC; Kim JH; Ha JW; Park NS; Sohng JK; Lee JW; Park SC; Kim MS; Seong CN
J Microbiol; 2007 Feb; 45(1):6-10. PubMed ID: 17342048
[TBL] [Abstract][Full Text] [Related]
2. Production, isolation and biological activity of nargenicin from Nocardia sp. CS682.
Sohng JK; Yamaguchi T; Seong CN; Baik KS; Park SC; Lee HJ; Jang SY; Simkhada JR; Yoo JC
Arch Pharm Res; 2008 Oct; 31(10):1339-45. PubMed ID: 18958426
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of Australian plant extracts against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
Palombo EA; Semple SJ
J Basic Microbiol; 2002; 42(6):444-8. PubMed ID: 12442307
[TBL] [Abstract][Full Text] [Related]
4. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
Fukumoto A; Kim YP; Hanaki H; Shiomi K; Tomoda H; Omura S
J Antibiot (Tokyo); 2008 Jan; 61(1):7-10. PubMed ID: 18305353
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterisation of a Streptomyces sp. isolate exhibiting activity against methicillin-resistant Staphylococcus aureus.
Higginbotham SJ; Murphy CD
Microbiol Res; 2010; 165(1):82-6. PubMed ID: 19231147
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
[TBL] [Abstract][Full Text] [Related]
8. Selection of Streptomyces isolates from Turkish karstic caves against antibiotic resistant microorganisms.
Yücel S; Yamaç M
Pak J Pharm Sci; 2010 Jan; 23(1):1-6. PubMed ID: 20067859
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus.
Sharma M; Manhas RK
BMC Microbiol; 2019 Feb; 19(1):44. PubMed ID: 30782119
[TBL] [Abstract][Full Text] [Related]
10. Solid-phase synthesis and antibacterial activity of hydroxycinnamic acid amides and analogues against methicillin-resistant Staphylococcus aureus and vancomycin-resistant S. aureus.
Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A
Bioorg Med Chem Lett; 2006 Nov; 16(22):5870-3. PubMed ID: 16942872
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
12. Studies on a new marine streptomycete BT-408 producing polyketide antibiotic SBR-22 effective against methicillin resistant Staphylococcus aureus.
Sujatha P; Bapi Raju KV; Ramana T
Microbiol Res; 2005; 160(2):119-26. PubMed ID: 15881828
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
[TBL] [Abstract][Full Text] [Related]
14. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.
Fukumoto A; Kim YP; Matsumoto A; Takahashi Y; Shiomi K; Tomoda H; Omura S
J Antibiot (Tokyo); 2008 Jan; 61(1):1-6. PubMed ID: 18305352
[TBL] [Abstract][Full Text] [Related]
15. A new class of anti-MRSA and anti-VRE agents: preparation and antibacterial activities of indole-containing compounds.
Yamamoto Y; Kurazono M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1626-8. PubMed ID: 17254785
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial protein from Streptomyces fulvissimus inhibitory to methicillin resistant Staphylococcus aureus.
Malik H; Sur B; Singhal N; Bihari V
Indian J Exp Biol; 2008 Apr; 46(4):254-7. PubMed ID: 18512335
[TBL] [Abstract][Full Text] [Related]
17. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
18. Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination.
Otter JA; Cummins M; Ahmad F; van Tonder C; Drabu YJ
J Hosp Infect; 2007 Oct; 67(2):182-8. PubMed ID: 17884250
[TBL] [Abstract][Full Text] [Related]
19. The antibacterial principle of Caesalpina sappan.
Xu HX; Lee SF
Phytother Res; 2004 Aug; 18(8):647-51. PubMed ID: 15476302
[TBL] [Abstract][Full Text] [Related]
20. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
